StockNews.com started coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a research note published on Saturday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright raised Onconova Therapeutics from a neutral rating to a buy rating and set a $11.00 price objective on the stock in a […]